Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin | 186 | 2013 | 1159 | 9.360 |
Why?
|
Islets of Langerhans | 73 | 2014 | 544 | 5.620 |
Why?
|
Diabetes Mellitus, Type 2 | 72 | 2014 | 1372 | 3.430 |
Why?
|
Blood Glucose | 129 | 2013 | 873 | 3.250 |
Why?
|
Glucose | 73 | 2013 | 637 | 3.220 |
Why?
|
Insulin-Secreting Cells | 21 | 2016 | 397 | 3.000 |
Why?
|
C-Peptide | 81 | 2013 | 174 | 2.740 |
Why?
|
Diabetes Mellitus | 28 | 2015 | 801 | 2.130 |
Why?
|
Trans-Activators | 9 | 2016 | 429 | 2.100 |
Why?
|
Insulin Resistance | 33 | 2014 | 377 | 2.010 |
Why?
|
Apoptosis | 17 | 2016 | 1678 | 1.830 |
Why?
|
Obesity | 38 | 2011 | 962 | 1.770 |
Why?
|
Homeodomain Proteins | 8 | 2016 | 535 | 1.720 |
Why?
|
Glucose Intolerance | 15 | 2012 | 96 | 1.660 |
Why?
|
Glucose Tolerance Test | 42 | 2012 | 228 | 1.370 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2014 | 199 | 1.320 |
Why?
|
Calpain | 8 | 2010 | 111 | 1.170 |
Why?
|
Glucagon | 37 | 2013 | 111 | 1.020 |
Why?
|
Diabetes Mellitus, Type 1 | 22 | 2010 | 566 | 1.020 |
Why?
|
Biomedical Research | 4 | 2015 | 375 | 0.940 |
Why?
|
Neurotensin | 3 | 2013 | 10 | 0.930 |
Why?
|
Membrane Proteins | 3 | 2014 | 1194 | 0.850 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 645 | 0.840 |
Why?
|
Gastric Inhibitory Polypeptide | 3 | 2012 | 9 | 0.830 |
Why?
|
Animals | 108 | 2016 | 26518 | 0.830 |
Why?
|
Calcium | 20 | 2013 | 1148 | 0.820 |
Why?
|
Mice | 48 | 2016 | 11313 | 0.810 |
Why?
|
Eating | 15 | 2002 | 166 | 0.780 |
Why?
|
Hyperglycemia | 11 | 2008 | 176 | 0.770 |
Why?
|
Proinsulin | 16 | 2012 | 124 | 0.730 |
Why?
|
Reference Values | 31 | 2009 | 673 | 0.700 |
Why?
|
Hypoglycemic Agents | 12 | 2013 | 377 | 0.700 |
Why?
|
Thiazolidinediones | 6 | 2005 | 82 | 0.670 |
Why?
|
Diabetes Mellitus, Experimental | 10 | 2016 | 190 | 0.670 |
Why?
|
Polycystic Ovary Syndrome | 5 | 2009 | 202 | 0.650 |
Why?
|
Humans | 183 | 2015 | 86281 | 0.650 |
Why?
|
Liver | 29 | 2007 | 1229 | 0.640 |
Why?
|
Hypoglycemia | 14 | 2009 | 106 | 0.610 |
Why?
|
Glucokinase | 8 | 2001 | 61 | 0.610 |
Why?
|
Rats, Zucker | 15 | 2003 | 38 | 0.610 |
Why?
|
Calcium-Binding Proteins | 3 | 2009 | 114 | 0.600 |
Why?
|
Male | 139 | 2013 | 40860 | 0.590 |
Why?
|
Mitochondrial Proteins | 2 | 2010 | 123 | 0.540 |
Why?
|
Circadian Rhythm | 15 | 2000 | 303 | 0.540 |
Why?
|
Fasting | 17 | 2010 | 161 | 0.510 |
Why?
|
Adult | 100 | 2013 | 25577 | 0.510 |
Why?
|
Thiazoles | 5 | 1998 | 131 | 0.500 |
Why?
|
Chromans | 4 | 1998 | 30 | 0.500 |
Why?
|
Mitochondria | 5 | 2006 | 535 | 0.490 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 2 | 2004 | 23 | 0.490 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2014 | 55 | 0.490 |
Why?
|
Cell Death | 2 | 2014 | 256 | 0.480 |
Why?
|
Female | 115 | 2013 | 44405 | 0.450 |
Why?
|
DNA-Binding Proteins | 7 | 2005 | 1208 | 0.440 |
Why?
|
Leucine | 2 | 2003 | 67 | 0.440 |
Why?
|
Glucose Clamp Technique | 15 | 2011 | 39 | 0.440 |
Why?
|
Glucagon-Like Peptide 1 | 5 | 2013 | 48 | 0.430 |
Why?
|
Mice, Knockout | 12 | 2014 | 1918 | 0.430 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 279 | 0.420 |
Why?
|
Exocytosis | 4 | 2009 | 108 | 0.420 |
Why?
|
Islets of Langerhans Transplantation | 6 | 2006 | 225 | 0.420 |
Why?
|
Calcium Signaling | 4 | 2006 | 129 | 0.410 |
Why?
|
Rats | 28 | 2012 | 3984 | 0.410 |
Why?
|
Potassium Channels, Inwardly Rectifying | 3 | 2009 | 118 | 0.410 |
Why?
|
NADP | 4 | 2006 | 45 | 0.400 |
Why?
|
Necrosis | 2 | 2010 | 204 | 0.390 |
Why?
|
Autophagy | 2 | 2009 | 148 | 0.390 |
Why?
|
Somatostatin | 15 | 1998 | 55 | 0.390 |
Why?
|
Incretins | 2 | 2009 | 14 | 0.390 |
Why?
|
Transcription Factors | 7 | 2005 | 1555 | 0.380 |
Why?
|
Muscle, Skeletal | 4 | 2012 | 448 | 0.370 |
Why?
|
Receptor, Insulin | 7 | 2009 | 54 | 0.370 |
Why?
|
Genetic Variation | 5 | 2010 | 1349 | 0.370 |
Why?
|
Mice, Transgenic | 12 | 2010 | 1537 | 0.370 |
Why?
|
TCF Transcription Factors | 1 | 2009 | 23 | 0.370 |
Why?
|
ADP-ribosyl Cyclase 1 | 2 | 2006 | 12 | 0.360 |
Why?
|
RNA, Messenger | 15 | 2014 | 1975 | 0.350 |
Why?
|
KATP Channels | 1 | 2009 | 19 | 0.350 |
Why?
|
Metabolic Clearance Rate | 26 | 2005 | 121 | 0.350 |
Why?
|
Education, Graduate | 1 | 2009 | 11 | 0.350 |
Why?
|
Pancreas | 8 | 2012 | 239 | 0.350 |
Why?
|
Dose-Response Relationship, Drug | 13 | 2006 | 1958 | 0.350 |
Why?
|
Models, Biological | 14 | 2008 | 1748 | 0.340 |
Why?
|
Chromosomes, Human, Pair 20 | 4 | 1996 | 32 | 0.340 |
Why?
|
Hyperinsulinism | 8 | 2009 | 51 | 0.340 |
Why?
|
Signal Transduction | 10 | 2014 | 3233 | 0.340 |
Why?
|
Mentors | 1 | 2009 | 76 | 0.330 |
Why?
|
History, 21st Century | 3 | 2015 | 175 | 0.330 |
Why?
|
Kinetics | 28 | 2002 | 1513 | 0.330 |
Why?
|
In Vitro Techniques | 13 | 2012 | 987 | 0.330 |
Why?
|
Gene Expression | 10 | 2006 | 1281 | 0.330 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2009 | 93 | 0.320 |
Why?
|
History, 20th Century | 3 | 2015 | 312 | 0.320 |
Why?
|
Dogs | 32 | 2004 | 684 | 0.300 |
Why?
|
Membrane Glycoproteins | 2 | 2006 | 428 | 0.300 |
Why?
|
Diet, Reducing | 3 | 2009 | 31 | 0.290 |
Why?
|
Lipoproteins | 3 | 1992 | 135 | 0.290 |
Why?
|
Hydrocortisone | 12 | 1999 | 298 | 0.290 |
Why?
|
Glucose Metabolism Disorders | 1 | 2006 | 3 | 0.290 |
Why?
|
Retinol-Binding Proteins | 1 | 2006 | 8 | 0.290 |
Why?
|
Histocompatibility | 1 | 2006 | 71 | 0.290 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2003 | 53 | 0.280 |
Why?
|
Up-Regulation | 3 | 2014 | 710 | 0.270 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2004 | 73 | 0.270 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2005 | 15 | 0.270 |
Why?
|
Bariatric Surgery | 1 | 2008 | 194 | 0.270 |
Why?
|
Triglycerides | 6 | 1996 | 232 | 0.270 |
Why?
|
Cells, Cultured | 7 | 2009 | 2810 | 0.270 |
Why?
|
Gene Expression Regulation | 9 | 2009 | 1917 | 0.270 |
Why?
|
Weight Loss | 7 | 2012 | 229 | 0.270 |
Why?
|
Aging | 7 | 2008 | 689 | 0.270 |
Why?
|
Lipids | 3 | 2009 | 269 | 0.260 |
Why?
|
Internal Medicine | 1 | 2009 | 347 | 0.260 |
Why?
|
Calcium Channels | 3 | 1996 | 182 | 0.260 |
Why?
|
Metformin | 2 | 1997 | 128 | 0.260 |
Why?
|
Egtazic Acid | 1 | 2004 | 34 | 0.250 |
Why?
|
Bcl-2-Like Protein 11 | 2 | 2014 | 22 | 0.250 |
Why?
|
Infusions, Intravenous | 15 | 2013 | 429 | 0.250 |
Why?
|
Cell Survival | 6 | 2010 | 966 | 0.250 |
Why?
|
Time Factors | 23 | 2013 | 5198 | 0.250 |
Why?
|
Fatty Acids, Nonesterified | 8 | 2000 | 70 | 0.250 |
Why?
|
Ginsenosides | 3 | 2012 | 123 | 0.240 |
Why?
|
Mutation | 10 | 2001 | 3952 | 0.240 |
Why?
|
Middle Aged | 47 | 2013 | 24957 | 0.230 |
Why?
|
Pulsatile Flow | 7 | 1996 | 49 | 0.230 |
Why?
|
Muscle Proteins | 1 | 2004 | 132 | 0.230 |
Why?
|
Genetic Therapy | 2 | 2003 | 342 | 0.230 |
Why?
|
Mice, Inbred C57BL | 11 | 2013 | 3087 | 0.220 |
Why?
|
Point Mutation | 4 | 1997 | 246 | 0.220 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 179 | 0.210 |
Why?
|
Nuclear Proteins | 4 | 2001 | 694 | 0.210 |
Why?
|
Proteins | 4 | 2001 | 777 | 0.210 |
Why?
|
Cell Count | 2 | 2014 | 194 | 0.210 |
Why?
|
Glucose Transporter Type 4 | 3 | 2006 | 17 | 0.210 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 2421 | 0.210 |
Why?
|
Glycolysis | 2 | 1999 | 129 | 0.200 |
Why?
|
Gene Knockdown Techniques | 2 | 2014 | 234 | 0.200 |
Why?
|
Glyburide | 3 | 1996 | 32 | 0.200 |
Why?
|
Potassium Chloride | 5 | 2004 | 86 | 0.190 |
Why?
|
Diabetes, Gestational | 3 | 1995 | 39 | 0.190 |
Why?
|
Pedigree | 11 | 2003 | 966 | 0.190 |
Why?
|
Body Weight | 10 | 2004 | 459 | 0.180 |
Why?
|
Portal Vein | 11 | 2006 | 120 | 0.180 |
Why?
|
Membrane Transport Proteins | 1 | 2001 | 166 | 0.180 |
Why?
|
Androgens | 3 | 1997 | 164 | 0.180 |
Why?
|
Panax | 3 | 2011 | 170 | 0.180 |
Why?
|
Internship and Residency | 1 | 2009 | 1001 | 0.180 |
Why?
|
Cell Line | 8 | 2014 | 2466 | 0.180 |
Why?
|
Energy Metabolism | 4 | 2009 | 271 | 0.180 |
Why?
|
Peptides | 7 | 2004 | 639 | 0.170 |
Why?
|
Energy Intake | 4 | 2009 | 97 | 0.170 |
Why?
|
Osmolar Concentration | 7 | 2001 | 181 | 0.170 |
Why?
|
Insulin Infusion Systems | 3 | 1997 | 36 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 189 | 0.170 |
Why?
|
Cell Division | 2 | 2001 | 696 | 0.170 |
Why?
|
Activity Cycles | 6 | 1998 | 19 | 0.160 |
Why?
|
Deoxyglucose | 3 | 2006 | 37 | 0.160 |
Why?
|
Perfusion | 6 | 2003 | 202 | 0.160 |
Why?
|
Arachidonic Acid | 1 | 1998 | 63 | 0.160 |
Why?
|
Blotting, Western | 3 | 2010 | 781 | 0.160 |
Why?
|
Periodicity | 6 | 1999 | 119 | 0.160 |
Why?
|
Membrane Potentials | 5 | 2006 | 435 | 0.160 |
Why?
|
Homeostasis | 6 | 2006 | 408 | 0.160 |
Why?
|
Postprandial Period | 5 | 2013 | 47 | 0.160 |
Why?
|
Leptin | 5 | 2009 | 105 | 0.160 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 5 | 2009 | 80 | 0.160 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 1996 | 65 | 0.160 |
Why?
|
Adenosine Triphosphate | 5 | 2001 | 314 | 0.160 |
Why?
|
Analysis of Variance | 8 | 2006 | 912 | 0.150 |
Why?
|
Microscopy, Fluorescence | 4 | 2013 | 424 | 0.150 |
Why?
|
Exercise | 2 | 2008 | 315 | 0.150 |
Why?
|
Sleep | 4 | 1997 | 440 | 0.150 |
Why?
|
Pancreas Transplantation | 3 | 1993 | 102 | 0.150 |
Why?
|
Fibrinolysis | 1 | 1997 | 35 | 0.150 |
Why?
|
Biological Clocks | 1 | 1998 | 74 | 0.150 |
Why?
|
Glycerolphosphate Dehydrogenase | 1 | 1996 | 6 | 0.150 |
Why?
|
Vitamin A | 3 | 1992 | 27 | 0.150 |
Why?
|
Thapsigargin | 3 | 2004 | 55 | 0.150 |
Why?
|
Pyruvate Carboxylase | 1 | 1996 | 6 | 0.150 |
Why?
|
Adrenocortical Hyperfunction | 1 | 1996 | 6 | 0.140 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 12 | 0.140 |
Why?
|
Protein Precursors | 4 | 2001 | 143 | 0.140 |
Why?
|
bcl-2-Associated X Protein | 1 | 2016 | 47 | 0.140 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1996 | 79 | 0.140 |
Why?
|
Injections, Intravenous | 8 | 2001 | 243 | 0.140 |
Why?
|
Dog Diseases | 1 | 1996 | 35 | 0.140 |
Why?
|
Arginine | 9 | 2009 | 136 | 0.140 |
Why?
|
Receptors, Drug | 2 | 2009 | 54 | 0.140 |
Why?
|
Steroids | 1 | 1997 | 172 | 0.140 |
Why?
|
Lipoproteins, HDL | 2 | 1994 | 96 | 0.140 |
Why?
|
Ovary | 1 | 1997 | 250 | 0.140 |
Why?
|
Organ Specificity | 5 | 2009 | 257 | 0.140 |
Why?
|
Potassium Channels | 4 | 2001 | 340 | 0.130 |
Why?
|
Growth Hormone | 7 | 1995 | 97 | 0.130 |
Why?
|
Rats, Wistar | 6 | 2012 | 296 | 0.130 |
Why?
|
Genotype | 3 | 2009 | 1850 | 0.130 |
Why?
|
Peptide Fragments | 5 | 2001 | 460 | 0.130 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2009 | 141 | 0.130 |
Why?
|
Patch-Clamp Techniques | 3 | 2004 | 396 | 0.130 |
Why?
|
Hypertriglyceridemia | 2 | 1994 | 67 | 0.130 |
Why?
|
Research Personnel | 1 | 2015 | 67 | 0.130 |
Why?
|
Ryanodine | 2 | 2004 | 4 | 0.120 |
Why?
|
Dantrolene | 2 | 2004 | 5 | 0.120 |
Why?
|
Food | 6 | 1996 | 85 | 0.120 |
Why?
|
Lentivirus | 1 | 2014 | 36 | 0.120 |
Why?
|
Missouri | 2 | 2013 | 19 | 0.120 |
Why?
|
Gastric Emptying | 1 | 2013 | 23 | 0.120 |
Why?
|
Insulinoma | 3 | 2004 | 37 | 0.120 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 547 | 0.120 |
Why?
|
Phosphoproteins | 2 | 2009 | 253 | 0.120 |
Why?
|
Administration, Oral | 6 | 1998 | 683 | 0.120 |
Why?
|
Ovarian Diseases | 1 | 1993 | 32 | 0.120 |
Why?
|
Haplotypes | 2 | 2014 | 642 | 0.110 |
Why?
|
Portraits as Topic | 1 | 2012 | 6 | 0.110 |
Why?
|
Blood Chemical Analysis | 1 | 1993 | 42 | 0.110 |
Why?
|
Diet | 4 | 2009 | 442 | 0.110 |
Why?
|
RNA Interference | 1 | 2014 | 368 | 0.110 |
Why?
|
History, 19th Century | 1 | 2012 | 59 | 0.110 |
Why?
|
Hyperthyroidism | 1 | 1993 | 75 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2015 | 377 | 0.110 |
Why?
|
Treatment Outcome | 6 | 2013 | 7949 | 0.110 |
Why?
|
Recombinant Proteins | 5 | 1996 | 1014 | 0.110 |
Why?
|
Tolbutamide | 5 | 2001 | 16 | 0.100 |
Why?
|
Jejunum | 1 | 2012 | 78 | 0.100 |
Why?
|
Duodenum | 1 | 2012 | 99 | 0.100 |
Why?
|
Body Mass Index | 8 | 2009 | 770 | 0.100 |
Why?
|
Sulfonylurea Receptors | 2 | 2009 | 50 | 0.100 |
Why?
|
Phytotherapy | 2 | 2002 | 132 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2010 | 96 | 0.100 |
Why?
|
Cyclophilins | 1 | 2010 | 8 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 5 | 2007 | 34 | 0.100 |
Why?
|
Gastric Bypass | 1 | 2012 | 110 | 0.100 |
Why?
|
Organ Size | 4 | 2009 | 363 | 0.100 |
Why?
|
Cholinergic Agonists | 1 | 2010 | 9 | 0.100 |
Why?
|
Transgenes | 2 | 2008 | 180 | 0.090 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2010 | 10 | 0.090 |
Why?
|
Carbachol | 1 | 2010 | 34 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 376 | 0.090 |
Why?
|
Hexoses | 1 | 1990 | 4 | 0.090 |
Why?
|
Overweight | 1 | 2011 | 118 | 0.090 |
Why?
|
Plant Extracts | 2 | 2002 | 243 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 2267 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2006 | 321 | 0.090 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2009 | 29 | 0.090 |
Why?
|
Autophagy-Related Protein 5 | 1 | 2009 | 11 | 0.090 |
Why?
|
Beclin-1 | 1 | 2009 | 14 | 0.090 |
Why?
|
Radioimmunoassay | 12 | 1997 | 155 | 0.090 |
Why?
|
Drug Synergism | 1 | 2010 | 303 | 0.090 |
Why?
|
Transcriptome | 1 | 2014 | 574 | 0.090 |
Why?
|
Culture Media | 1 | 2009 | 146 | 0.090 |
Why?
|
Starvation | 1 | 2009 | 23 | 0.090 |
Why?
|
Body Composition | 1 | 2009 | 68 | 0.090 |
Why?
|
United States | 3 | 2012 | 6637 | 0.090 |
Why?
|
Personnel, Hospital | 1 | 2009 | 30 | 0.090 |
Why?
|
DNA Fragmentation | 2 | 2000 | 63 | 0.090 |
Why?
|
Washington | 1 | 2009 | 48 | 0.090 |
Why?
|
Heparin | 4 | 1999 | 175 | 0.090 |
Why?
|
Government Regulation | 1 | 2009 | 49 | 0.090 |
Why?
|
Glucagon-Secreting Cells | 1 | 2009 | 25 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2012 | 219 | 0.090 |
Why?
|
Program Development | 1 | 2009 | 124 | 0.090 |
Why?
|
Adipose Tissue | 3 | 2006 | 240 | 0.090 |
Why?
|
Intracellular Membranes | 2 | 2001 | 117 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2009 | 115 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2009 | 153 | 0.080 |
Why?
|
Universities | 1 | 2009 | 135 | 0.080 |
Why?
|
Carboxypeptidase H | 1 | 2008 | 12 | 0.080 |
Why?
|
Palmitates | 1 | 2008 | 18 | 0.080 |
Why?
|
Amino Acids | 1 | 2009 | 252 | 0.080 |
Why?
|
Prevalence | 1 | 2012 | 1239 | 0.080 |
Why?
|
Cognition Disorders | 1 | 1990 | 236 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 176 | 0.080 |
Why?
|
Sex Characteristics | 3 | 2004 | 319 | 0.080 |
Why?
|
Workload | 1 | 2009 | 128 | 0.080 |
Why?
|
Program Evaluation | 1 | 2009 | 297 | 0.080 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 339 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2002 | 1752 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 6 | 1 | 2007 | 5 | 0.080 |
Why?
|
Kidney | 3 | 1983 | 1240 | 0.080 |
Why?
|
Schools, Medical | 1 | 2009 | 123 | 0.080 |
Why?
|
Ion Channels | 2 | 2001 | 245 | 0.080 |
Why?
|
Mice, Obese | 3 | 2002 | 44 | 0.080 |
Why?
|
Mice, Mutant Strains | 2 | 2008 | 229 | 0.080 |
Why?
|
Career Choice | 1 | 2009 | 139 | 0.080 |
Why?
|
Transplantation, Homologous | 2 | 2006 | 996 | 0.080 |
Why?
|
Pancreatic Polypeptide | 4 | 1998 | 9 | 0.080 |
Why?
|
Gonadotropins | 2 | 1997 | 34 | 0.080 |
Why?
|
Cognition | 1 | 1992 | 570 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 1 | 4 | 2001 | 30 | 0.080 |
Why?
|
Proteome | 1 | 2008 | 124 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2005 | 1135 | 0.080 |
Why?
|
Health Care Costs | 1 | 2009 | 237 | 0.070 |
Why?
|
Secretory Rate | 4 | 1993 | 13 | 0.070 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2006 | 3 | 0.070 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 250 | 0.070 |
Why?
|
Protein Isoforms | 2 | 2004 | 269 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2006 | 314 | 0.070 |
Why?
|
Brain | 3 | 1991 | 2211 | 0.070 |
Why?
|
Microscopy, Confocal | 2 | 2004 | 268 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2010 | 576 | 0.070 |
Why?
|
Histocompatibility Testing | 1 | 2006 | 154 | 0.070 |
Why?
|
NAD | 1 | 2006 | 65 | 0.070 |
Why?
|
Computational Biology | 1 | 2009 | 528 | 0.070 |
Why?
|
Electron Transport | 1 | 2006 | 71 | 0.070 |
Why?
|
Adolescent | 9 | 2001 | 8968 | 0.070 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2005 | 7 | 0.070 |
Why?
|
Cytosol | 1 | 2006 | 189 | 0.070 |
Why?
|
Amino Acid Sequence | 7 | 2000 | 2062 | 0.070 |
Why?
|
Half-Life | 4 | 1987 | 96 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 1999 | 632 | 0.070 |
Why?
|
Pancreatectomy | 3 | 1986 | 148 | 0.070 |
Why?
|
Chromosome Mapping | 3 | 2000 | 1074 | 0.070 |
Why?
|
Enzyme Activation | 2 | 2004 | 692 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2006 | 283 | 0.070 |
Why?
|
Proteomics | 1 | 2006 | 211 | 0.060 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 2 | 1996 | 13 | 0.060 |
Why?
|
HLA Antigens | 1 | 2006 | 232 | 0.060 |
Why?
|
Molecular Sequence Data | 8 | 2000 | 3029 | 0.060 |
Why?
|
Epinephrine | 5 | 1992 | 84 | 0.060 |
Why?
|
Factor V | 1 | 2004 | 10 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 1381 | 0.060 |
Why?
|
Cell Separation | 3 | 2003 | 196 | 0.060 |
Why?
|
Protein Transport | 1 | 2006 | 410 | 0.060 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2004 | 6 | 0.060 |
Why?
|
Palmitic Acids | 1 | 2004 | 8 | 0.060 |
Why?
|
Genes | 2 | 1995 | 305 | 0.060 |
Why?
|
Glucagon-Like Peptides | 1 | 2004 | 8 | 0.060 |
Why?
|
Macrocyclic Compounds | 1 | 2004 | 7 | 0.060 |
Why?
|
Oxazoles | 1 | 2004 | 19 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 850 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2003 | 2227 | 0.060 |
Why?
|
Reaction Time | 4 | 2002 | 309 | 0.060 |
Why?
|
Matched-Pair Analysis | 1 | 2003 | 43 | 0.060 |
Why?
|
Age of Onset | 2 | 2001 | 306 | 0.060 |
Why?
|
Proprotein Convertase 1 | 1 | 2003 | 11 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 9 | 1997 | 315 | 0.060 |
Why?
|
Mathematics | 3 | 2005 | 190 | 0.060 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 1610 | 0.060 |
Why?
|
Endocrine System | 1 | 2003 | 17 | 0.060 |
Why?
|
Risk Assessment | 2 | 2009 | 2253 | 0.060 |
Why?
|
Caspase 3 | 1 | 2004 | 159 | 0.060 |
Why?
|
Caspases | 1 | 2004 | 155 | 0.060 |
Why?
|
Endosomes | 1 | 2004 | 75 | 0.060 |
Why?
|
Aged | 15 | 2012 | 18353 | 0.060 |
Why?
|
Human Growth Hormone | 3 | 2002 | 54 | 0.060 |
Why?
|
Betacellulin | 1 | 2003 | 3 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2003 | 123 | 0.060 |
Why?
|
Dipeptides | 1 | 2003 | 46 | 0.060 |
Why?
|
Spectrum Analysis | 2 | 1993 | 118 | 0.060 |
Why?
|
Lipolysis | 2 | 1994 | 22 | 0.060 |
Why?
|
Risk Factors | 3 | 2009 | 5397 | 0.060 |
Why?
|
Pregnancy | 5 | 2001 | 2885 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2009 | 1571 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 285 | 0.060 |
Why?
|
Superoxides | 1 | 2003 | 73 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 253 | 0.060 |
Why?
|
Immunoassay | 3 | 2008 | 92 | 0.060 |
Why?
|
Forecasting | 2 | 1996 | 303 | 0.050 |
Why?
|
Tissue Distribution | 4 | 1997 | 290 | 0.050 |
Why?
|
Acromegaly | 1 | 2002 | 5 | 0.050 |
Why?
|
Anti-Obesity Agents | 1 | 2002 | 14 | 0.050 |
Why?
|
Oxidation-Reduction | 1 | 2003 | 373 | 0.050 |
Why?
|
Antigens, CD | 1 | 2004 | 457 | 0.050 |
Why?
|
Dexamethasone | 1 | 2003 | 326 | 0.050 |
Why?
|
Polymerase Chain Reaction | 5 | 1997 | 927 | 0.050 |
Why?
|
Diterpenes | 2 | 1992 | 20 | 0.050 |
Why?
|
Adenoviridae | 1 | 2003 | 345 | 0.050 |
Why?
|
Base Sequence | 6 | 1996 | 2329 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2003 | 165 | 0.050 |
Why?
|
Uncoupling Protein 2 | 1 | 2001 | 11 | 0.050 |
Why?
|
Uncoupling Agents | 1 | 2001 | 15 | 0.050 |
Why?
|
Genetic Markers | 3 | 2000 | 476 | 0.050 |
Why?
|
Electric Conductivity | 1 | 2001 | 144 | 0.050 |
Why?
|
Intestine, Small | 1 | 2003 | 303 | 0.050 |
Why?
|
Indians, North American | 1 | 2001 | 48 | 0.050 |
Why?
|
Pregnancy in Diabetics | 1 | 2001 | 37 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2004 | 242 | 0.050 |
Why?
|
Area Under Curve | 1 | 2002 | 334 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2004 | 192 | 0.050 |
Why?
|
Biomarkers | 3 | 2013 | 1709 | 0.050 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2000 | 85 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2013 | 399 | 0.050 |
Why?
|
Oligopeptides | 1 | 2001 | 179 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2009 | 672 | 0.050 |
Why?
|
Somatostatin-28 | 4 | 1983 | 4 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 1997 | 286 | 0.050 |
Why?
|
Adipocytes | 1 | 2001 | 155 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2000 | 52 | 0.050 |
Why?
|
Pancreatic Neoplasms | 3 | 1997 | 645 | 0.050 |
Why?
|
Nitrendipine | 1 | 1999 | 5 | 0.040 |
Why?
|
Promoter Regions, Genetic | 2 | 2008 | 937 | 0.040 |
Why?
|
Diazoxide | 1 | 1999 | 19 | 0.040 |
Why?
|
Diabetic Neuropathies | 4 | 1988 | 40 | 0.040 |
Why?
|
Pancreatic Hormones | 2 | 1991 | 15 | 0.040 |
Why?
|
Glyceraldehyde | 1 | 1998 | 4 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 1999 | 187 | 0.040 |
Why?
|
Polymorphism, Genetic | 2 | 2000 | 819 | 0.040 |
Why?
|
Dietary Fats | 3 | 2008 | 134 | 0.040 |
Why?
|
Calcium-Transporting ATPases | 1 | 1998 | 29 | 0.040 |
Why?
|
Sarcoplasmic Reticulum | 1 | 1998 | 24 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 1999 | 203 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 1998 | 34 | 0.040 |
Why?
|
Wakefulness | 2 | 1995 | 134 | 0.040 |
Why?
|
Chromatography, Gel | 4 | 1992 | 103 | 0.040 |
Why?
|
Cholesterol | 3 | 2002 | 356 | 0.040 |
Why?
|
Hexokinase | 1 | 1997 | 19 | 0.040 |
Why?
|
Transfection | 2 | 2004 | 895 | 0.040 |
Why?
|
Guinea Pigs | 1 | 1997 | 171 | 0.040 |
Why?
|
Leuprolide | 1 | 1997 | 30 | 0.040 |
Why?
|
Pregnancy, Animal | 1 | 1997 | 57 | 0.040 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 1997 | 36 | 0.040 |
Why?
|
Consumer Behavior | 1 | 1997 | 29 | 0.040 |
Why?
|
Genetic Testing | 1 | 2001 | 535 | 0.040 |
Why?
|
Double-Blind Method | 3 | 1998 | 1822 | 0.040 |
Why?
|
Keratins | 1 | 1997 | 63 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 1996 | 17 | 0.040 |
Why?
|
Arcuate Nucleus of Hypothalamus | 1 | 1996 | 16 | 0.040 |
Why?
|
Child | 4 | 2001 | 6913 | 0.040 |
Why?
|
Genes, Dominant | 1 | 1996 | 117 | 0.040 |
Why?
|
RNA, Transfer, Leu | 1 | 1996 | 11 | 0.040 |
Why?
|
Infusions, Parenteral | 2 | 1986 | 50 | 0.040 |
Why?
|
Purinergic P2 Receptor Agonists | 1 | 1996 | 3 | 0.040 |
Why?
|
Phosphorylation | 3 | 2006 | 1101 | 0.040 |
Why?
|
Regression Analysis | 4 | 2000 | 595 | 0.040 |
Why?
|
Deafness | 1 | 1996 | 47 | 0.040 |
Why?
|
Diabetic Angiopathies | 1 | 1996 | 62 | 0.040 |
Why?
|
Acarbose | 1 | 1995 | 2 | 0.030 |
Why?
|
Keratinocytes | 1 | 1997 | 143 | 0.030 |
Why?
|
Trisaccharides | 1 | 1995 | 12 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2001 | 724 | 0.030 |
Why?
|
Uterus | 1 | 1997 | 214 | 0.030 |
Why?
|
Skin Transplantation | 1 | 1997 | 172 | 0.030 |
Why?
|
Weaning | 1 | 1995 | 25 | 0.030 |
Why?
|
Liver Circulation | 4 | 1983 | 30 | 0.030 |
Why?
|
Phenotype | 3 | 2003 | 2375 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 1997 | 378 | 0.030 |
Why?
|
Causality | 1 | 1995 | 81 | 0.030 |
Why?
|
Age Factors | 2 | 1997 | 1842 | 0.030 |
Why?
|
Cohort Studies | 2 | 2001 | 2759 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2009 | 679 | 0.030 |
Why?
|
Electrophysiology | 1 | 1996 | 401 | 0.030 |
Why?
|
Synaptic Transmission | 1 | 1996 | 222 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 1999 | 589 | 0.030 |
Why?
|
Uncertainty | 1 | 2015 | 71 | 0.030 |
Why?
|
Pulse | 1 | 1994 | 18 | 0.030 |
Why?
|
Femoral Artery | 2 | 1986 | 81 | 0.030 |
Why?
|
Diet, Diabetic | 1 | 1994 | 4 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2006 | 2699 | 0.030 |
Why?
|
Adenoma, Islet Cell | 2 | 1986 | 28 | 0.030 |
Why?
|
Cell Dedifferentiation | 1 | 2014 | 8 | 0.030 |
Why?
|
Cholesterol, HDL | 2 | 1994 | 165 | 0.030 |
Why?
|
Preventive Medicine | 1 | 2014 | 17 | 0.030 |
Why?
|
Expert Testimony | 1 | 2014 | 46 | 0.030 |
Why?
|
Receptors, Neurotensin | 1 | 2013 | 3 | 0.030 |
Why?
|
Inulin | 1 | 1993 | 17 | 0.030 |
Why?
|
Plaque, Amyloid | 1 | 2014 | 56 | 0.030 |
Why?
|
DNA | 3 | 1997 | 1293 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 4 | 2 | 2007 | 30 | 0.030 |
Why?
|
Antisense Elements (Genetics) | 1 | 1993 | 9 | 0.030 |
Why?
|
Testosterone | 1 | 1995 | 268 | 0.030 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2014 | 83 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2014 | 116 | 0.030 |
Why?
|
Family | 1 | 1995 | 311 | 0.030 |
Why?
|
Glycerol | 1 | 1993 | 32 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1993 | 126 | 0.030 |
Why?
|
Insulin Antibodies | 1 | 1992 | 2 | 0.030 |
Why?
|
Adenylate Kinase | 1 | 2012 | 13 | 0.030 |
Why?
|
Lipid Metabolism | 2 | 1990 | 196 | 0.030 |
Why?
|
Body Surface Area | 1 | 1992 | 36 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2004 | 280 | 0.030 |
Why?
|
Blood Pressure | 2 | 1996 | 1143 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 916 | 0.030 |
Why?
|
Statistics as Topic | 1 | 1993 | 237 | 0.030 |
Why?
|
Fruit | 2 | 2002 | 75 | 0.030 |
Why?
|
Lipase | 1 | 1991 | 22 | 0.030 |
Why?
|
Plant Preparations | 1 | 2011 | 19 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2012 | 347 | 0.020 |
Why?
|
Thyroxine | 1 | 1993 | 344 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2014 | 446 | 0.020 |
Why?
|
Autoantibodies | 1 | 1992 | 267 | 0.020 |
Why?
|
Self Care | 1 | 1992 | 164 | 0.020 |
Why?
|
Myocardium | 1 | 1993 | 528 | 0.020 |
Why?
|
Child, Preschool | 4 | 2001 | 3608 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2010 | 29 | 0.020 |
Why?
|
Somatomedins | 1 | 1990 | 28 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1990 | 33 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2010 | 97 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 1990 | 30 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 133 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 77 | 0.020 |
Why?
|
Actins | 1 | 1993 | 448 | 0.020 |
Why?
|
Remission Induction | 1 | 2012 | 722 | 0.020 |
Why?
|
Perilipin-1 | 1 | 2009 | 7 | 0.020 |
Why?
|
Fluorine Radioisotopes | 1 | 1990 | 25 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 476 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 1990 | 103 | 0.020 |
Why?
|
Brain Chemistry | 1 | 1990 | 121 | 0.020 |
Why?
|
Evoked Potentials, Visual | 1 | 1990 | 87 | 0.020 |
Why?
|
Algorithms | 2 | 2000 | 1828 | 0.020 |
Why?
|
Hybridization, Genetic | 1 | 2010 | 104 | 0.020 |
Why?
|
Cyclosporine | 1 | 2010 | 234 | 0.020 |
Why?
|
Streptozocin | 1 | 2009 | 54 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 1990 | 138 | 0.020 |
Why?
|
Physical Exertion | 1 | 1988 | 39 | 0.020 |
Why?
|
Basal Metabolism | 1 | 1988 | 20 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2010 | 509 | 0.020 |
Why?
|
Young Adult | 2 | 2012 | 5961 | 0.020 |
Why?
|
Heterozygote | 2 | 2001 | 365 | 0.020 |
Why?
|
Cyclosporins | 1 | 1988 | 59 | 0.020 |
Why?
|
Inflammation | 1 | 2014 | 913 | 0.020 |
Why?
|
Animal Feed | 1 | 2008 | 20 | 0.020 |
Why?
|
Placebos | 2 | 1999 | 218 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2008 | 48 | 0.020 |
Why?
|
Molecular Weight | 5 | 1990 | 332 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2004 | 1671 | 0.020 |
Why?
|
Calibration | 1 | 2008 | 99 | 0.020 |
Why?
|
Heterochromatin | 1 | 2007 | 22 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 1988 | 239 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2007 | 17 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 104 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2008 | 117 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2008 | 188 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 159 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2006 | 3616 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 207 | 0.020 |
Why?
|
Clinical Chemistry Tests | 1 | 2007 | 11 | 0.020 |
Why?
|
X Chromosome | 1 | 2007 | 152 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1988 | 268 | 0.020 |
Why?
|
Transplantation, Autologous | 4 | 1991 | 328 | 0.020 |
Why?
|
Central Nervous System | 1 | 2007 | 151 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 1997 | 307 | 0.020 |
Why?
|
International Cooperation | 1 | 2007 | 126 | 0.020 |
Why?
|
Alleles | 1 | 2010 | 1127 | 0.020 |
Why?
|
Hepatic Veins | 2 | 1983 | 27 | 0.020 |
Why?
|
Computer Simulation | 1 | 1991 | 1077 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2005 | 6481 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 21 | 0.020 |
Why?
|
Opportunistic Infections | 1 | 2006 | 59 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 64 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2009 | 324 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 85 | 0.020 |
Why?
|
Glycogen | 1 | 2006 | 59 | 0.020 |
Why?
|
Syndrome | 1 | 1987 | 446 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 64 | 0.020 |
Why?
|
Autonomic Nervous System | 2 | 1983 | 56 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1990 | 380 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 1992 | 846 | 0.020 |
Why?
|
Isoantibodies | 1 | 2006 | 114 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1990 | 788 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1996 | 416 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2004 | 57 | 0.020 |
Why?
|
Culture Techniques | 1 | 2004 | 91 | 0.020 |
Why?
|
DNA Primers | 2 | 1996 | 542 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2004 | 245 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 1996 | 646 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2004 | 134 | 0.020 |
Why?
|
Graft Survival | 1 | 1988 | 883 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2006 | 751 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2006 | 373 | 0.020 |
Why?
|
Plasmids | 1 | 2004 | 287 | 0.020 |
Why?
|
Gastrins | 1 | 2003 | 15 | 0.020 |
Why?
|
Pro-Opiomelanocortin | 1 | 2003 | 12 | 0.020 |
Why?
|
Calcitonin | 1 | 2003 | 38 | 0.020 |
Why?
|
Endothelium | 1 | 2004 | 59 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1990 | 731 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2004 | 369 | 0.010 |
Why?
|
Renin | 1 | 2003 | 78 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 2 | 1997 | 371 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2004 | 144 | 0.010 |
Why?
|
Hepatectomy | 1 | 1984 | 166 | 0.010 |
Why?
|
Sugar Alcohol Dehydrogenases | 1 | 1983 | 2 | 0.010 |
Why?
|
Imidazolidines | 1 | 1983 | 5 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 266 | 0.010 |
Why?
|
Aldehyde Reductase | 1 | 1983 | 9 | 0.010 |
Why?
|
Intercalating Agents | 1 | 2003 | 12 | 0.010 |
Why?
|
Ethidium | 1 | 2003 | 13 | 0.010 |
Why?
|
Heart Rate | 3 | 1996 | 492 | 0.010 |
Why?
|
Neural Conduction | 1 | 1983 | 69 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 305 | 0.010 |
Why?
|
Cell Cycle | 1 | 2004 | 502 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 877 | 0.010 |
Why?
|
Norepinephrine | 1 | 1982 | 167 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2002 | 21 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 689 | 0.010 |
Why?
|
Saponins | 1 | 2002 | 41 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 102 | 0.010 |
Why?
|
Follicle Stimulating Hormone | 1 | 2002 | 147 | 0.010 |
Why?
|
Imidazoles | 1 | 1983 | 163 | 0.010 |
Why?
|
Arizona | 1 | 2001 | 10 | 0.010 |
Why?
|
Body Constitution | 1 | 2001 | 26 | 0.010 |
Why?
|
Cell Size | 1 | 2001 | 65 | 0.010 |
Why?
|
Ultrasonography | 1 | 2004 | 695 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 2002 | 62 | 0.010 |
Why?
|
Nuclear Family | 1 | 2001 | 92 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 114 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 350 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 977 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 122 | 0.010 |
Why?
|
Estradiol | 1 | 2002 | 249 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1985 | 584 | 0.010 |
Why?
|
Finland | 1 | 2000 | 29 | 0.010 |
Why?
|
Antibodies | 1 | 1983 | 349 | 0.010 |
Why?
|
Mexican Americans | 1 | 2000 | 63 | 0.010 |
Why?
|
Fetus | 1 | 2001 | 226 | 0.010 |
Why?
|
Specimen Handling | 1 | 2001 | 98 | 0.010 |
Why?
|
Mothers | 1 | 2001 | 140 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1984 | 418 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2003 | 480 | 0.010 |
Why?
|
Metyrapone | 1 | 1999 | 3 | 0.010 |
Why?
|
Adenoma | 1 | 2002 | 234 | 0.010 |
Why?
|
Fat Emulsions, Intravenous | 1 | 1999 | 13 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1999 | 86 | 0.010 |
Why?
|
Drug Combinations | 1 | 1999 | 222 | 0.010 |
Why?
|
Gene Frequency | 1 | 2000 | 676 | 0.010 |
Why?
|
Homozygote | 1 | 1998 | 200 | 0.010 |
Why?
|
Rats, Mutant Strains | 1 | 1997 | 23 | 0.010 |
Why?
|
Oxygen | 1 | 2003 | 725 | 0.010 |
Why?
|
Receptors, Leptin | 1 | 1997 | 32 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1997 | 54 | 0.010 |
Why?
|
Proline | 1 | 1997 | 57 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1996 | 157 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 274 | 0.010 |
Why?
|
Neuropeptide Y | 1 | 1996 | 31 | 0.010 |
Why?
|
Gastrectomy | 1 | 1997 | 68 | 0.010 |
Why?
|
Oscillometry | 1 | 1996 | 25 | 0.010 |
Why?
|
Genomic Imprinting | 1 | 1996 | 33 | 0.010 |
Why?
|
Adenosine Monophosphate | 1 | 1996 | 27 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1996 | 55 | 0.010 |
Why?
|
Thionucleotides | 1 | 1996 | 56 | 0.010 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1996 | 44 | 0.010 |
Why?
|
Prognosis | 1 | 2004 | 3669 | 0.010 |
Why?
|
Adenine | 1 | 1996 | 85 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 1995 | 64 | 0.010 |
Why?
|
Cattle | 1 | 1996 | 374 | 0.010 |
Why?
|
Societies, Scientific | 1 | 1996 | 44 | 0.010 |
Why?
|
Genome, Human | 1 | 2000 | 756 | 0.010 |
Why?
|
Hypogonadism | 1 | 1995 | 37 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1995 | 81 | 0.010 |
Why?
|
Guanine | 1 | 1996 | 208 | 0.010 |
Why?
|
Feedback | 1 | 1995 | 132 | 0.010 |
Why?
|
Lipoproteins, HDL2 | 1 | 1994 | 5 | 0.010 |
Why?
|
Lipoproteins, HDL3 | 1 | 1994 | 8 | 0.010 |
Why?
|
Glucose Transporter Type 2 | 1 | 1994 | 10 | 0.010 |
Why?
|
Particle Size | 1 | 1994 | 121 | 0.010 |
Why?
|
Molecular Probes | 1 | 1994 | 35 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1994 | 502 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 2183 | 0.010 |
Why?
|
Veins | 1 | 1994 | 94 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 1993 | 70 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 1997 | 853 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 1214 | 0.010 |
Why?
|
Skin | 1 | 1997 | 554 | 0.010 |
Why?
|
Adenosine | 1 | 1996 | 224 | 0.010 |
Why?
|
Fatty Acids | 1 | 1993 | 129 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1997 | 1562 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1992 | 129 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1991 | 62 | 0.010 |
Why?
|
Denervation | 1 | 1991 | 34 | 0.010 |
Why?
|
Creatinine | 1 | 1992 | 337 | 0.010 |
Why?
|
Hepatic Artery | 2 | 1981 | 82 | 0.010 |
Why?
|
Sex Factors | 1 | 1994 | 1053 | 0.010 |
Why?
|
Regional Blood Flow | 2 | 1981 | 197 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 3347 | 0.010 |
Why?
|
Anaerobiosis | 1 | 1988 | 21 | 0.010 |
Why?
|
Cardiac Output | 1 | 1988 | 156 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1990 | 480 | 0.000 |
Why?
|
Respiration | 1 | 1988 | 261 | 0.000 |
Why?
|
Cross Reactions | 1 | 1986 | 106 | 0.000 |
Why?
|
Papio | 1 | 1986 | 82 | 0.000 |
Why?
|
Stroke Volume | 1 | 1988 | 452 | 0.000 |
Why?
|
Swine | 1 | 1987 | 554 | 0.000 |
Why?
|
Autonomic Nervous System Diseases | 1 | 1985 | 19 | 0.000 |
Why?
|
Tissue Donors | 1 | 1988 | 462 | 0.000 |
Why?
|
Infant | 1 | 1991 | 3036 | 0.000 |
Why?
|
Liver Regeneration | 1 | 1984 | 32 | 0.000 |
Why?
|
Injections, Subcutaneous | 1 | 1984 | 117 | 0.000 |
Why?
|
Liver Cirrhosis | 1 | 1986 | 296 | 0.000 |
Why?
|
Chromatography | 1 | 1983 | 28 | 0.000 |
Why?
|
Renal Circulation | 1 | 1983 | 61 | 0.000 |
Why?
|
Peroneal Nerve | 1 | 1983 | 9 | 0.000 |
Why?
|
Skin Temperature | 1 | 1983 | 14 | 0.000 |
Why?
|
Median Nerve | 1 | 1983 | 11 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1983 | 141 | 0.000 |
Why?
|
Antibody Specificity | 1 | 1983 | 129 | 0.000 |
Why?
|
Epitopes | 1 | 1983 | 255 | 0.000 |
Why?
|
Random Allocation | 1 | 1983 | 332 | 0.000 |
Why?
|
Portal System | 1 | 1981 | 13 | 0.000 |
Why?
|
Motor Neurons | 1 | 1983 | 161 | 0.000 |
Why?
|
Secretin | 1 | 1981 | 6 | 0.000 |
Why?
|
Kidney Failure, Chronic | 1 | 1986 | 509 | 0.000 |
Why?
|
Species Specificity | 1 | 1982 | 678 | 0.000 |
Why?
|